» Articles » PMID: 37238418

Elevated Urinary Hepcidin Level and Hypoferremia in Infants with Febrile Urinary Tract Infection: A Prospective Cohort Study

Overview
Specialty Health Services
Date 2023 May 27
PMID 37238418
Authors
Affiliations
Soon will be listed here.
Abstract

To evaluate the kinetics of serum and urinary hepcidin levels along with anemia-related parameters during the infection course of infants with febrile urinary tract infection (UTI), we enrolled febrile infants aged one to four months in this prospective study. Febrile patients with UTI were allocated into () or non- groups according to urine culture results. Septic workup, blood hepcidin, iron profile, urinalysis, and urinary hepcidin-creatinine ratio were collected upon admission and 3 days after antibiotic treatment. In total, 118 infants were included. On admission, the febrile UTI group showed a significant reduction in serum iron level and a significant elevation of urinary hepcidin-creatinine ratio compared to the febrile control counterpart. Moreover, urinary hepcidin-creatinine ratio had the highest odds ratio, 2.01, in logistics regression analysis. After 3 days of antibiotic treatment, hemoglobin and the urinary hepcidin-creatinine ratio were significantly decreased. Patients with an UTI had a significantly decreased urinary hepcidin-creatinine ratio after 3 days of antibiotics treatment, whereas the non- group showed insignificant changes. Our study suggested that the urinary hepcidin-creatinine ratio elevated during acute febrile urinary tract infection and significantly decreased after 3 days of antibiotics treatment, especially in UTI.

Citing Articles

Biomarkers of Brain Dysfunction in Perinatal Iron Deficiency.

Rao R Nutrients. 2024; 16(7).

PMID: 38613125 PMC: 11013337. DOI: 10.3390/nu16071092.


Nutritional Modulation of Hepcidin in the Treatment of Various Anemic States.

DAndrea P, Giampieri F, Battino M Nutrients. 2023; 15(24).

PMID: 38140340 PMC: 10745534. DOI: 10.3390/nu15245081.


Erythrocytapheresis in Children and Young Adults with Hemoglobinopathies and Iron Overload in Need of Iron Chelation Therapy.

van Hattem J, Maes P, Esterhuizen T, Devos A, Ruppert M, Van Heerden J J Clin Med. 2023; 12(19).

PMID: 37834930 PMC: 10573872. DOI: 10.3390/jcm12196287.


Hemoglobin and Its Z Score Reference Intervals in Febrile Children: A Cohort Study of 98,572 Febrile Children.

Cheng C, Hsu T, Yang Y, Huang Y Children (Basel). 2023; 10(8).

PMID: 37628401 PMC: 10453815. DOI: 10.3390/children10081402.


Correlations between Sleep Features and Iron Status in Children with Neurodevelopmental Disorders: A Cross-Sectional Study.

Giambersio D, Marzulli L, Margari L, Matera E, Nobili L, De Grandis E J Clin Med. 2023; 12(15).

PMID: 37568350 PMC: 10420017. DOI: 10.3390/jcm12154949.

References
1.
Houamel D, Ducrot N, Lefebvre T, Daher R, Moulouel B, Sari M . Hepcidin as a Major Component of Renal Antibacterial Defenses against Uropathogenic Escherichia coli. J Am Soc Nephrol. 2015; 27(3):835-46. PMC: 4769187. DOI: 10.1681/ASN.2014101035. View

2.
Sdogou T, Tsentidis C, Gourgiotis D, Marmarinos A, Gkourogianni A, Papassotiriou I . Immunoassay-based serum hepcidin reference range measurements in healthy children: differences among age groups. J Clin Lab Anal. 2014; 29(1):10-4. PMC: 6807248. DOI: 10.1002/jcla.21719. View

3.
Robinson J, Finlay J, Lang M, Bortolussi R . Urinary tract infections in infants and children: Diagnosis and management. Paediatr Child Health. 2014; 19(6):315-25. PMC: 4173959. DOI: 10.1093/pch/19.6.315. View

4.
Yang Y, Kuo H, Chen K, Chu C, Kuo K, Guo M . Combination of Hemoglobin-for-Age Z-Score and Plasma Hepcidin Identified as a Novel Predictor for Kawasaki Disease. Children (Basel). 2022; 9(6). PMC: 9222120. DOI: 10.3390/children9060913. View

5.
Semrin G, Fishman D, Bousvaros A, Zholudev A, Saunders A, Correia C . Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation. Inflamm Bowel Dis. 2006; 12(12):1101-6. PMC: 2788427. DOI: 10.1097/01.mib.0000235097.86360.04. View